Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Crick news > Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery

Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery

Researchers at the Crick and GSK will extend their ongoing collaboration to advance the discovery of new drug targets in a £11.5million effort.
7 Apr 2021
United Kingdom
Crick news

To view this News Article please log in or create a profile

Similar stories

Scientists from the Crick's Ancient Genomics lab were featured on the popular television show to discuss how their work … More...

We're sending our congratulations to all the Crick PhD students who submitted their theses last month. More...

Enara Bio has announced $32.5 million in Series B financing to advance its pipeline of TCR-based immunotherapies against… More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk


This website is powered by
ToucanTech